Concepedia

Joseph P. Horrigan

JP

Statistics

Publications

23

Citations

1.5K

H-Index

18

Active since

1995

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United States)

GlaxoSmithKline (United Kingdom)

University of North Carolina at Chapel Hill

Baylor College of Medicine

Joseph P. Horrigan is an author at Research Triangle Park Foundation specializing in medicine, pharmacotherapy, and psychopharmacology.

Publications per year

1995–2024

23

Publications

23

Bupropion XL in adults with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled study

Timothy E. Wilens, Barbara R. Haight, Joseph P. Horrigan et al. · Biological Psychiatry · 2005 · 194 citations

Medicine, Pharmacology, Pharmacotherapy +10

Risperidone and Explosive Aggressive Autism

Joseph P. Horrigan, L. Jarrett Barnhill · Journal of Autism and Developmental Disorders · 1997 · 123 citations

Medicine, Pharmacotherapy, Psychiatry +12

Guanfacine for Treatment of Attention-Deficit Hyperactivity Disorder in Boys

Joseph P. Horrigan, L. Jarrett Barnhill · Journal of Child and Adolescent Psychopharmacology · 1995 · 117 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

A Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of the H<sub>3</sub> Receptor Antagonist, GSK239512 as a Monotherapy in Subjects with Mild-to-Moderate Alzheimer’s Disease

Richard Grove, Conn Harrington, Andreas Mahler et al. · Current Alzheimer Research · 2014 · 109 citations

Medicine, Pharmacology, Pharmacotherapy +17

A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Rett Syndrome

Daniel G. Glaze, Jeffrey L. Neul, Alan K. Percy et al. · Pediatric Neurology · 2017 · 107 citations

Medicine, Endocrinology, Pharmacology +3

1–5 of 23